clinical trial · NCT07292233
A Food Effect Study of LY03020 in Healthy Subjects
SchizophreniaAlzheimer's Disease PsychosisLY03020
brief summary
This is a randomized, open-label, single-dose, two-period, crossover study to assess the food effect on pharmacokinetics (PK) and safety of LY03020 in healthy subjects.
started
Jul 30, 2025
primary completion
Aug 27, 2025
completion
Mar 30, 2026
last updated
Dec 18, 2025
official title
A Randomized, Open-Label, Single-Dose, Two-Period, Crossover Phase I Clinical Study to Evaluate the Food Effect on the Pharmacokinetics of LPM787000048 Maleate Extended-Release Tablets (LY03020) in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol